Market Report, "Leukemia - Pipeline Review, 2015", published

From: Fast Market Research, Inc.
Published: Sun Oct 25 2015

GlobalData's Medical Devices sector report, "Leukemia - Pipeline Review, 2015" provides an overview of Leukemia diagnostic tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Leukemia diagnostic tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Full Report Details at

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Report Scope

* Extensive coverage of the Leukemia diagnostic tests under development
* The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
* The report reviews the major players involved in the development of Leukemia diagnostic tests and list all their pipeline projects
* The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
* The report provides key clinical trial data of ongoing trials specific to pipeline products
* Recent developments in the segment / industry

Reasons to Get this Report

The report enables you to -

* Formulate significant competitor information, analysis, and insights to improve R&D strategies
* Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
* Identify and understand important and diverse types of Leukemia diagnostic tests under development
* Develop market-entry and market expansion strategies
* Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
* In-depth analysis of the product's current stage of development, territory and estimated launch date

Companies Mentioned in this Report: Abbott Diagnostics, Acobiom, Adaptive Biotechnologies Corporation, BioSense Technologies, Inc., Cancer Genetics, Inc., Cepheid, Di.V.A.L Toscana srl, Diagnovus, LLC, DiaSorin S.p.A, Eutropics Pharmaceuticals, Inc., Gendiag, Health Discovery Corporation, InVivoScribe Technologies, Inc., IV Diagnostics, Inc., Jaden BioScience Inc., MolecularMD, Corp., Monoquant Pty. Ltd., Nodality, Inc., NuCana BioMed Limited, Nuclea Biotechnologies Inc., OncoVista Innovative Therapies, Inc., Qiagen N.V., Siemens Healthcare Diagnostics Inc., Skyline Diagnostics BV, St. Jude Children's Research Hospital, Inc., The Feinstein Institute for Medical Research, University of Barcelona, University of California, San Diego, University of Missouri, Vela Diagnostics, Vivia Biotech, S.L., Wake Forest Baptist Medical Center, Xiamen Zeesan Biotech Co.,Ltd

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Acquired Gene or Chromosome Alterations - Pipeline Review, 2015
- Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2015
- Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015
- Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015
- Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2015

Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email:
Contact Phone: 1-413-485-7001

Visit website »